The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes
- PMID: 7946932
- PMCID: PMC1364832
- DOI: 10.1111/j.1365-2125.1994.tb04316.x
The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes
Abstract
1. Tacrine (1,2,3,4-tetrahydro-9-aminoacridine-hydrochloride: THA) underwent metabolism in vitro by a panel (n = 12) of human liver microsomes genotyped for CYP2D6, in the presence of NADPH, to both protein-reactive and stable metabolites. 2. There was considerable variation in the extent of THA metabolism amongst human livers. Protein-reactive metabolite formation showed a 10-fold variation (0.6 +/- 0.1%-5.2 +/- 0.8% of incubated radioactivity mg-1 protein) whilst stable metabolites showed a 3-fold variation (24.3 +/- 1.7%-78.6 +/- 2.6% of incubated radioactivity). 3. Using cytochrome P450 isoform specific inhibitors CYP1A2 was identified as the major enzyme involved in all routes of THA metabolism. 4. There was a high correlation between aromatic and alicyclic hydroxylation (r = 0.92, P < 0.0001) consistent with these biotransformations being catalysed by the same enzymes. 5. Enoxacin (ENOX), cimetidine (CIM) and chloroquine (CQ) inhibited THA metabolism by a preferential decrease in the bioactivation to protein-reactive, and hence potentially toxic, species. The inhibitory potency of ENOX and CIM was increased significantly upon pre-incubation with microsomes and NADPH. 6. Covalent binding correlated with 7-OH-THA formation before (r = 0.792, P < 0.0001) and after (r = 0.73, P < 0.0001) inhibition by CIM, consistent with a two-step mechanism in the formation of protein-reactive metabolite(s) via a 7-OH intermediate. 7. The use of enzyme inhibitors may provide a useful tool for examining the relationship between the metabolism and toxicity of THA in vivo.
Similar articles
-
An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro. Studies with human and rat liver microsomes.Biochem Pharmacol. 1993 Jul 6;46(1):13-20. doi: 10.1016/0006-2952(93)90342-t. Biochem Pharmacol. 1993. PMID: 8347124
-
Species variation in the bioactivation of tacrine by hepatic microsomes.Xenobiotica. 1995 Jan;25(1):103-16. doi: 10.3109/00498259509061837. Xenobiotica. 1995. PMID: 7604602
-
Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.Drug Metab Dispos. 1993 Sep-Oct;21(5):874-82. Drug Metab Dispos. 1993. PMID: 7902251
-
An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems.Br J Clin Pharmacol. 1995 Oct;40(4):369-78. doi: 10.1111/j.1365-2125.1995.tb04559.x. Br J Clin Pharmacol. 1995. PMID: 8554939 Free PMC article.
-
Characterisation of the cytochrome P450 enzymes involved in the in vitro metabolism of granisetron.Br J Clin Pharmacol. 1994 Dec;38(6):557-66. doi: 10.1111/j.1365-2125.1994.tb04397.x. Br J Clin Pharmacol. 1994. PMID: 7888294 Free PMC article.
Cited by
-
Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. Clin Pharmacokinet. 2009. PMID: 19902987
-
NAT gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variant.BMC Med Genet. 2004 Mar 17;5:6. doi: 10.1186/1471-2350-5-6. BMC Med Genet. 2004. PMID: 15142281 Free PMC article.
-
Clinical pharmacokinetics of tacrine.Clin Pharmacokinet. 1995 Jun;28(6):449-57. doi: 10.2165/00003088-199528060-00003. Clin Pharmacokinet. 1995. PMID: 7656503 Review.
-
Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites.J Chem Inf Model. 2020 Oct 26;60(10):4702-4716. doi: 10.1021/acs.jcim.0c00360. Epub 2020 Sep 16. J Chem Inf Model. 2020. PMID: 32881497 Free PMC article.
-
Preclinical evaluation of [18F]SYN1 and [18F]SYN2, novel radiotracers for PET myocardial perfusion imaging.EJNMMI Res. 2024 Jul 8;14(1):63. doi: 10.1186/s13550-024-01122-5. EJNMMI Res. 2024. PMID: 38976101 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources